Total Clarity Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$1K 226
2021
Q4
$1K Sell
200
-1,000
-83% -$5K ﹤0.01% 940
2021
Q3
$6K Buy
+1,200
New +$6K ﹤0.01% 770
2021
Q2
Sell
-1,200
Closed -$6K 205
2021
Q1
$6K Buy
+1,200
New +$6K ﹤0.01% 641